BIOMAT Database Logo BIOMAT Database Logo

Overexpression of bcl-2 or bcl-XL fails to inhibit apoptosis mediated by a novel retinoid. 1998

J A Fontana, and R J Sun, and A K Rishi, and M I Dawson, and J V Ordónez, and Y Zhang, and S H Tschang, and K Bhalla, and Z Han, and J Wyche, and G Poirer, and M S Sheikh, and B Shroot, and U Reichert
Department of Medicine, Marlene and Stewart Greenebaum Cancer Center, University of Maryland at Baltimore, USA.

Overexpression of bcl-2 or bcl-XL has been found to inhibit the induction of apoptosis in malignant cells by a large number of agents including a wide variety of chemotherapeutic drugs. CD437 ¿6-[3-(1-adamantyl)-4 hydroxyphenyl]-2-naphthalene carboxylic acid¿ is a novel retinoid that induces apoptosis in a number of malignant cells through a unique mechanism of action. The addition of 1 microM CD437 to HL-60/NEO cells resulted in capase 3 (CPP32) activation and poly(ADP-ribose) polymerase (PARP) cleavage in 3 h whereas in bcl-2- or bcl-XL-overexpressing HL-60 cells CD437 induced CPP32 activation and PARP cleavage in 6 h. Although 50 and 300 nM CD437 were required to induce PARP cleavage in HL-60/NEO and HL-60/bcl-2, HL-60/bcl-XL cells, respectively, maximal apoptosis in both cell lines was achieved utilizing 300 nM CD437. All three cell lines, however, share identical dose-response curves in terms of their growth inhibition, suggesting that CD437-mediated inhibition of growth and induction of apoptosis represent two distinct and separable processes. In addition, CD437 induces GI arrest as well as p21WAFI/CIPI mRNA expression in these cells despite the overexpression of bcl-2 or bcl-XL. CD437 induced mitochondrial instability as indicated by cytochrome c leakage into the cytoplasm in all three cell lines. CD437 also induced growth inhibition and apoptosis of an apoptosis-resistant variant of the HL-60 cell line (HCW-2), which switched expression from bcl-2 to bcl-XL. CD437-mediated apoptosis is not accompanied by downregulation of bcl-2 or bcl-XL or upregulation of bax. The reason for the inability of bcl-2 or bcl-XL overexpression to inhibit CD437-mediated apoptosis is unclear. The ability of CD437 to initiate apoptosis in a spectrum of malignant cells without interference from bcl-2 or bcl-XL overexpression suggests that CD437 may possess significant therapeutic potential in the treatment of malignancy.

UI MeSH Term Description Entries
D008928 Mitochondria Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed) Mitochondrial Contraction,Mitochondrion,Contraction, Mitochondrial,Contractions, Mitochondrial,Mitochondrial Contractions
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D003574 Cytochrome c Group A group of cytochromes with covalent thioether linkages between either or both of the vinyl side chains of protoheme and the protein. (Enzyme Nomenclature, 1992, p539) Cytochromes Type c,Group, Cytochrome c,Type c, Cytochromes
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D012176 Retinoids A group of tetraterpenes, with four terpene units joined head-to-tail. Biologically active members of this class are used clinically in the treatment of severe cystic ACNE; PSORIASIS; and other disorders of keratinization. Retinoid
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated

Related Publications

J A Fontana, and R J Sun, and A K Rishi, and M I Dawson, and J V Ordónez, and Y Zhang, and S H Tschang, and K Bhalla, and Z Han, and J Wyche, and G Poirer, and M S Sheikh, and B Shroot, and U Reichert
Suppression of apoptosis by Bcl-2 or Bcl-xL promotes susceptibility to mutagenesis.
October 1996, Oncogene,
J A Fontana, and R J Sun, and A K Rishi, and M I Dawson, and J V Ordónez, and Y Zhang, and S H Tschang, and K Bhalla, and Z Han, and J Wyche, and G Poirer, and M S Sheikh, and B Shroot, and U Reichert
Suppression of apoptosis by overexpression of Bcl-2 or Bcl-xL promotes survival and mutagenesis after oxidative damage.
October 1997, Biochimie,
J A Fontana, and R J Sun, and A K Rishi, and M I Dawson, and J V Ordónez, and Y Zhang, and S H Tschang, and K Bhalla, and Z Han, and J Wyche, and G Poirer, and M S Sheikh, and B Shroot, and U Reichert
Overexpression of Bcl-2 or Bcl-XL transgenes and photoreceptor degeneration.
November 1996, Investigative ophthalmology & visual science,
J A Fontana, and R J Sun, and A K Rishi, and M I Dawson, and J V Ordónez, and Y Zhang, and S H Tschang, and K Bhalla, and Z Han, and J Wyche, and G Poirer, and M S Sheikh, and B Shroot, and U Reichert
Overexpression of HA-Bax but not Bcl-2 or Bcl-XL attenuates 6-hydroxydopamine-induced neuronal apoptosis.
November 1998, Experimental neurology,
J A Fontana, and R J Sun, and A K Rishi, and M I Dawson, and J V Ordónez, and Y Zhang, and S H Tschang, and K Bhalla, and Z Han, and J Wyche, and G Poirer, and M S Sheikh, and B Shroot, and U Reichert
Prevention of myeloma cell apoptosis by ectopic bcl-2 expression or interleukin 6-mediated up-regulation of bcl-xL.
June 1995, Cancer research,
J A Fontana, and R J Sun, and A K Rishi, and M I Dawson, and J V Ordónez, and Y Zhang, and S H Tschang, and K Bhalla, and Z Han, and J Wyche, and G Poirer, and M S Sheikh, and B Shroot, and U Reichert
Regulation of lymphoid apoptosis by Bcl-2 and Bcl-XL.
January 1996, Advances in experimental medicine and biology,
J A Fontana, and R J Sun, and A K Rishi, and M I Dawson, and J V Ordónez, and Y Zhang, and S H Tschang, and K Bhalla, and Z Han, and J Wyche, and G Poirer, and M S Sheikh, and B Shroot, and U Reichert
Bcl-xL overexpression restricts gamma-radiation-induced apoptosis.
January 2006, Cell biology international,
J A Fontana, and R J Sun, and A K Rishi, and M I Dawson, and J V Ordónez, and Y Zhang, and S H Tschang, and K Bhalla, and Z Han, and J Wyche, and G Poirer, and M S Sheikh, and B Shroot, and U Reichert
NF-κB activation fails to protect cells to TNFα-induced apoptosis in the absence of Bcl-xL, but not Mcl-1, Bcl-2 or Bcl-w.
May 2013, Biochimica et biophysica acta,
J A Fontana, and R J Sun, and A K Rishi, and M I Dawson, and J V Ordónez, and Y Zhang, and S H Tschang, and K Bhalla, and Z Han, and J Wyche, and G Poirer, and M S Sheikh, and B Shroot, and U Reichert
Bcl-2 and Bcl-xL inhibit CD95-mediated apoptosis by preventing mitochondrial release of Smac/DIABLO and subsequent inactivation of X-linked inhibitor-of-apoptosis protein.
March 2002, The Journal of biological chemistry,
J A Fontana, and R J Sun, and A K Rishi, and M I Dawson, and J V Ordónez, and Y Zhang, and S H Tschang, and K Bhalla, and Z Han, and J Wyche, and G Poirer, and M S Sheikh, and B Shroot, and U Reichert
Glucocorticoids inhibit apoptosis during fibrosarcoma development by transcriptionally activating Bcl-xL.
May 2003, The Journal of biological chemistry,
Copied contents to your clipboard!